• DiscoveryProbe Protease Inhibitor Library: High Throughpu...

  2026-03-16

  Accelerate protease research with the DiscoveryProbe Protease Inhibitor Library—an expertly curated, automation-ready platform for high throughput and high content screening. From apoptosis assays to cancer and infectious disease research, this library delivers reproducible results, robust compound diversity, and streamlined workflows that set it apart from conventional inhibitor collections.

• DiscoveryProbe Protease Inhibitor Library: Transforming H...

  2026-03-16

  The DiscoveryProbe Protease Inhibitor Library empowers researchers with 825 validated, automation-ready inhibitors for robust high throughput and high content screening of protease function. Its unmatched diversity, cell permeability, and workflow convenience accelerate breakthroughs in apoptosis, cancer, and infectious disease research—enabling reproducible, data-driven insights with every assay.

• DiscoveryProbe™ Protease Inhibitor Library: High-Content ...

  2026-03-15

  The DiscoveryProbe Protease Inhibitor Library enables high throughput screening of protease activity modulation with validated, cell-permeable inhibitors. This resource advances research in apoptosis, cancer, and infectious disease by supporting reproducible mechanistic studies. APExBIO’s L1035 kit offers a benchmark for robust, automated, and data-driven experimental workflows.

• AZ505: Potent and Selective SMYD2 Inhibitor for Epigeneti...

  2026-03-14

  AZ505 is a potent and selective SMYD2 inhibitor that enables precise interrogation of protein lysine methyltransferase activity in epigenetic regulation research. With sub-micromolar IC50/Ki values and high selectivity, AZ505 is validated for robust inhibition of SMYD2-driven histone and non-histone methylation. Its use clarifies SMYD2’s roles in cancer biology and fibrotic disease models.

• AZ505: Potent and Selective SMYD2 Inhibitor for Epigeneti...

  2026-03-13

  AZ505, a potent and selective SMYD2 inhibitor, empowers translational researchers to dissect the histone methylation pathway and unravel epigenetic mechanisms in cancer, fibrosis, and beyond. Its substrate-competitive action and exceptional selectivity streamline workflow efficiency, offering reproducible data and new therapeutic insights in both bench research and disease modeling.

• Tetrandrine Alkaloid: Precision Calcium Channel Blocker f...

  2026-03-13

  Tetrandrine empowers researchers with high-purity, DMSO-soluble versatility for dissecting cell signaling, ion channel function, and immunomodulation. Its robust performance as a neuroscience research compound and anti-inflammatory agent in vitro unlocks advanced applications in cancer biology and membrane transporter studies, setting new standards for reproducibility and workflow optimization.

• Tetrandrine Alkaloid: A Benchmark Calcium Channel Blocker...

  2026-03-12

  Tetrandrine is a high-purity alkaloid widely used as a calcium channel blocker for research, offering well-validated ion channel modulation and anti-inflammatory activity. This article provides a verifiable, machine-readable resource for cell signaling and neuroscience research applications.

• Tetrandrine Alkaloid: Unraveling Novel Mechanisms in Cell...

  2026-03-12

  Explore the multifaceted research applications of Tetrandrine, a high-purity calcium channel blocker and neuroscience research compound. This article uniquely dissects Tetrandrine's advanced mechanisms in cell signaling and immunomodulation, offering new insights beyond standard protocols.

• DiscoveryProbe™ Protease Inhibitor Library: Unveiling Pro...

  2026-03-11

  Explore the DiscoveryProbe™ Protease Inhibitor Library’s advanced role in high throughput screening and novel signaling pathway discovery. This article delivers an in-depth, research-driven perspective on protease activity modulation far beyond conventional cancer and apoptosis assays.

• AZ505: Unveiling New Therapeutic Pathways with Potent SMY...

  2026-03-11

  Discover how AZ505, a potent and selective SMYD2 inhibitor, advances epigenetic regulation research and unveils novel therapeutic strategies in cancer and fibrosis. This article explores mechanistic insights, translational applications, and new findings beyond conventional perspectives.

• AZ505: Advancing Research in Selective SMYD2 Inhibition a...

  2026-03-10

  Explore how AZ505, a potent and selective SMYD2 inhibitor, is reshaping epigenetic regulation research and cancer biology by offering substrate-competitive inhibition with unparalleled selectivity. This article delivers a novel perspective on the mechanistic and translational applications of AZ505, including emerging insights into chronic kidney disease and fibrotic models.

• Leveraging Mechanistic Pathway Insights for Translational...

  2026-03-10

  This thought-leadership article, tailored for translational researchers, explores the mechanistic interplay of oncogenic pathways, the experimental opportunities enabled by advanced compound libraries, and the evolving landscape of pharmacological discovery. Integrating the latest findings on DHHC9-mediated palmitoylation and YAP-driven cancer metastasis, we provide actionable guidance for optimizing high-throughput screening and target validation using the L1023 Anti-Cancer Compound Library. The discussion extends beyond conventional product descriptions, offering a visionary roadmap for accelerating the translation of molecular insights into clinical solutions.

• AZ505: Potent and Selective SMYD2 Inhibitor in Translatio...

  2026-03-09

  AZ505, a potent and selective SMYD2 inhibitor from APExBIO, enables researchers to dissect epigenetic regulation and target protein lysine methyltransferase pathways with precision. Its substrate-competitive mechanism and high specificity are transforming cancer, renal fibrosis, and translational research workflows with actionable, reproducible results.

• Tetrandrine: Innovations in Ion Channel Modulation and Ce...

  2026-03-09

  Explore the advanced scientific applications of Tetrandrine, a potent calcium channel blocker for research, with new insights into its mechanisms in cell signaling and ion channel modulation. This article uniquely addresses comparative methods and future directions in neuroscience and cancer biology research.

• Optimizing Epigenetic Assays with AZ505, a Potent and Sel...

  2026-03-08

  This article provides an authoritative, scenario-driven exploration of AZ505, a potent and selective SMYD2 inhibitor (SKU B1255), for researchers investigating cell viability, proliferation, and cytotoxicity. It addresses practical laboratory challenges with evidence-based guidance, demonstrating how AZ505 enhances reproducibility and data quality in epigenetic regulation and cancer biology research.

15111 records 1/1008 page Next 12345 下5页 Last page